Measles IgG Immunity Threshold
Any measles IgG antibody level above the standard positive cutoff value of the licensed assay being used indicates immunity and viral clearance 1. There is no single universal mIU/mL number that applies across all laboratory assays.
Key Interpretation Principles
The critical concept is that immunity is assay-dependent, not based on a fixed numerical threshold. According to ACIP guidelines, any antibody level exceeding the positive cutoff of a licensed assay constitutes evidence of immunity 1. This approach recognizes that different laboratory methods (ELISA, latex agglutination, immunofluorescence, passive hemagglutination, virus neutralization) have varying sensitivities and cutoff values.
Common Misconceptions About the 120 mIU/mL Threshold
While 120 mIU/mL is frequently cited as a correlate of protection, this threshold lacks robust scientific validation. A 2020 systematic review found only 5 studies supporting this commonly used threshold, and notably, some symptomatic measles cases occurred in individuals with pre-exposure titers exceeding 120 mIU/mL 2. The variation in laboratory methods between studies made direct comparisons difficult, underscoring the limited evidence base for this specific number.
Alternative Thresholds in Research
Different studies have used varying thresholds:
- 200 mIU/mL: Used as a protective cutoff in some pediatric studies 3
- 320 mIU/mL: Defined as protective in HIV-infected children with immune recovery 4
These discrepancies further emphasize that no single numerical value universally defines immunity across all populations and assay methods.
Clinical Application
For practical purposes:
- Use the positive cutoff value provided by your specific laboratory's licensed assay
- Any result reported as "positive" or "immune" by that assay indicates adequate immunity
- Persons with "equivocal" results should be considered susceptible unless they have other evidence of immunity (documented vaccination, physician-diagnosed measles, or birth before 1957) 1
Important Caveats
- Assay sensitivity matters: More sensitive tests (like ELISA) may detect antibodies that older methods (like hemagglutination inhibition) miss 1
- Apparent antibody loss: Some individuals who "lose" detectable antibodies by less sensitive tests still have immunity demonstrable by more sensitive assays or by showing a booster response (rapid IgG rise without IgM) upon revaccination 1
- Timing of testing: For acute infection diagnosis, IgM may not be detectable until 72 hours after rash onset 1
The bottom line: Trust your laboratory's positive cutoff rather than searching for a universal mIU/mL number.